NOV 14 - 15 2018

Clinical Diagnostics & Research 2018

Our 9th Annual Clinical Diagnostics & Research  Virtual Event is now available On Demand!

Clinical diagnostics is an ever-changing field of medicine and research, challenged with combining several different scientific disciplines into one for the sake of diagnosis and treatment of human disease. The constant flux in the field is due to continuous progress made with advances in laboratory testing and patient care and treatment. With new technologies and treatments available, updates in regulatory processes are also necessary to ensure patient safety and proper practices.

By bringing together clinicians, researchers, medical experts and professionals from around the world, LabRoots aims to help drive collaborations and in turn, advances in clinical diagnostics, research and medicine. This complementary conference offers an amazing opportunity to benefit from interacting with a global community of like-minded colleagues from the comfort of home.

Topic's for this years event included: 

  • POC/POC Testing
  • Regulatory
  • Pain Management
  • Laboratory Testing and Management
  • Opioids
  • Hematology/Cardio
  • Informatics/Med Data Analytics


Our virtual conference allows you to participate in a global setting with no travel or cost to you. You can participate in exactly those parts which you are interested in and be back at your desk or bench in an instant. Virtual events remove time and place restrictions and ensure that everyone who wants to participate can do so. This virtual conference also offers increased reach for the global clinical community with a high degree of interaction through live-streaming video and chat sessions.

Call for Speakers  We are always looking to feature excellent research during our virtual events. If you’re working on some remarkable breakthroughs and would like to submit a speaker or panel for consideration, please submit your abstract here.


Continuing Education
By participating in this virtual event and watching webcast presentations, you can earn Free Continuing Education (PACE) and/or Continuing Medical Education (CME) credits. To earn educational credits, you must view an entire presentation. Following the presentation, you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit.

Don't forget to participate in our Leaderboard and Scavenger Hunt to win one of our Free Science T-shirts!  

Use #LRclinical to follow the conversation!


Speakers

Show Resources
You May Also Like
NOV 02, 2016 06:00 AM PDT
C.E. CREDITS
NOV 02, 2016 06:00 AM PDT
The 7th annual Clinical Diagnostics & Research conference is now On Demand!  This premiere venue discusses the latest advances in clinical diagnostics, research and medicine. The con...
SEP 14, 2016 06:30 AM PDT
C.E. CREDITS
SEP 14, 2016 06:30 AM PDT
An industry leader in delivering instrument systems, reagents, and services to life science researchers,Beckman Coulter Life Sciences helps enable new discoveries in biology-based research...
NOV 08, 2017 06:00 AM PST
C.E. CREDITS
NOV 08, 2017 06:00 AM PST
LabRoots invites you to the 8th annual Clinical Diagnostics & Research free online conference! Clinical diagnostics is an ever-changing field of medicine and research, challenged wit...
MAY 28, 2014 06:00 AM PDT
C.E. CREDITS
MAY 28, 2014 06:00 AM PDT
This year will be our 5th annual Clinical Diagnostics & Research online conference. Attendees can earn free CME and CE Credits. The theme of this conference is a range of medical and clin...
NOV 11, 2015 06:00 AM PST
C.E. CREDITS
NOV 11, 2015 06:00 AM PST
Welcome to LabRoots’ 6th Annual Clinical Diagnostics & Research free online conference! The event is now available on-demand and you can attend sessions including keynotes...
FEB 22, 2017 06:00 AM PST
C.E. CREDITS
FEB 22, 2017 06:00 AM PST
Precision Medicine 2017 was a success and is now availabe On Demand!Imagine receiving a full diagnosis from a simple blood test, or the ability to tailor the perfect treatment to your ind...
Agenda
  • NOV 14, 2018 06:00 AM PST
    Improving Sepsis Management with Same-Day Results from the Lab
    Speaker: John McDonough
  • NOV 14, 2018 07:30 AM PST
    Keynote Presentation: Diagnostic Management Teams - Implementation Obstacles
    Speaker: Michael Laposata, MD, PhD
  • NOV 14, 2018 09:00 AM PST
    Accelerating Cancer Research and Clinical Innovations Using OncoLand
    Speaker: Bing Zhou, PhD
    Sponsored By: QIAGEN
  • NOV 14, 2018 10:30 AM PST
    Ultimate Innovation in Clinical Research Applications Using the Agilent Ultivo Triple Quadrupole LC/MS
    Speaker: Julie Cichelli, PhD
    Sponsored By: Agilent
  • NOV 14, 2018 12:00 PM PST
    Automated Variant Classification in QIAGEN Clinical Insight Shows Near Perfect Concordance with ClinVar Expert Panel Assessments
    Speaker: Jennifer Poitras, PhD
    Sponsored By: QIAGEN
  • NOV 14, 2018 01:30 PM PST
    Challenges of PTH Testing in Patients with CKD
    Speaker: Ravinder Singh, PhD
  • NOV 15, 2018 06:00 AM PST
    How Do We Effectively Screen and Manage Opioid Use in the Community?
    Speaker: Carissa van den Berk-Clark, PhD
  • NOV 15, 2018 07:30 AM PST
    Keynote Presentation: Standardizing Point-of-Care Instrumentation: One Institution's Experience
    Speaker: Brenda Suh-Lailam, PhD
  • NOV 15, 2018 09:00 AM PST
    Best Practice Strategies and Tools for Scaling Clinical Bioinformatics
    Speaker: Elaine Gee, PhD
  • NOV 15, 2018 09:00 AM PST
    Comprehensive Genomic Profiling Becoming a New Standard-of-Care in Oncology
    Sponsored By: Illumina
    Phillip Febbo, MD
    Chief Medical Officer, Illumina, Inc.
    Maude Champagne
    Clinical Oncology Marketing, Illumina, Inc.
  • NOV 15, 2018 10:30 AM PST
    Cervical Cancer: Everlasting World Health Challenge
    Speaker: Olivera Markovic, MD, PhD
  • NOV 15, 2018 10:30 AM PST
    Management of HPV-Positive Women by QIAsure Methylation Test
    Speaker: Chris Meijer, MD, PhD
    Sponsored By: QIAGEN
  • NOV 15, 2018 12:00 PM PST
    Better Knowledge, Better Care: Precision Medicine for Any Cancer, Any Assay, on Your Platform
    Sponsored By: QIAGEN
    Raed Samara, PhD
    Senior Global Product Manager, NGS, QIAGEN
    Dan Richards, PhD
    Vice President, Biomedical Informatics, QIAGEN
  • NOV 15, 2018 12:00 PM PST
    The Washington State Department of Health's Prescription Monitoring Program - Ensuring Safe Prescribing
    Speaker: Gary Garrety
  • NOV 15, 2018 01:30 PM PST
    Washington's New Opioid Prescribing Rules
    Speaker: Blake Maresh, MPA, CMBE
  • Point of Care
  • NOV 14, 2018 06:00 AM PST
    Improving Sepsis Management with Same-Day Results from the Lab
    Speaker: John McDonough
  • NOV 15, 2018 07:30 AM PST
    Keynote Presentation: Standardizing Point-of-Care Instrumentation: One Institution's Experience
    Speaker: Brenda Suh-Lailam, PhD
  • NOV 15, 2018 09:00 AM PST
    Comprehensive Genomic Profiling Becoming a New Standard-of-Care in Oncology
    Sponsored By: Illumina
    Phillip Febbo, MD
    Chief Medical Officer, Illumina, Inc.
    Maude Champagne
    Clinical Oncology Marketing, Illumina, Inc.
  • NOV 15, 2018 10:30 AM PST
    Cervical Cancer: Everlasting World Health Challenge
    Speaker: Olivera Markovic, MD, PhD
  • Laboratory Testing & Management
  • NOV 14, 2018 07:30 AM PST
    Keynote Presentation: Diagnostic Management Teams - Implementation Obstacles
    Speaker: Michael Laposata, MD, PhD
  • NOV 14, 2018 10:30 AM PST
    Ultimate Innovation in Clinical Research Applications Using the Agilent Ultivo Triple Quadrupole LC/MS
    Speaker: Julie Cichelli, PhD
    Sponsored By: Agilent
  • NOV 14, 2018 01:30 PM PST
    Challenges of PTH Testing in Patients with CKD
    Speaker: Ravinder Singh, PhD
  • NOV 15, 2018 10:30 AM PST
    Management of HPV-Positive Women by QIAsure Methylation Test
    Speaker: Chris Meijer, MD, PhD
    Sponsored By: QIAGEN
  • Informatics/Med Data Analytics
  • NOV 14, 2018 09:00 AM PST
    Accelerating Cancer Research and Clinical Innovations Using OncoLand
    Speaker: Bing Zhou, PhD
    Sponsored By: QIAGEN
  • NOV 14, 2018 12:00 PM PST
    Automated Variant Classification in QIAGEN Clinical Insight Shows Near Perfect Concordance with ClinVar Expert Panel Assessments
    Speaker: Jennifer Poitras, PhD
    Sponsored By: QIAGEN
  • NOV 15, 2018 09:00 AM PST
    Best Practice Strategies and Tools for Scaling Clinical Bioinformatics
    Speaker: Elaine Gee, PhD
  • NOV 15, 2018 12:00 PM PST
    Better Knowledge, Better Care: Precision Medicine for Any Cancer, Any Assay, on Your Platform
    Sponsored By: QIAGEN
    Raed Samara, PhD
    Senior Global Product Manager, NGS, QIAGEN
    Dan Richards, PhD
    Vice President, Biomedical Informatics, QIAGEN
  • Opiods
  • NOV 15, 2018 06:00 AM PST
    How Do We Effectively Screen and Manage Opioid Use in the Community?
    Speaker: Carissa van den Berk-Clark, PhD
  • NOV 15, 2018 12:00 PM PST
    The Washington State Department of Health's Prescription Monitoring Program - Ensuring Safe Prescribing
    Speaker: Gary Garrety
  • NOV 15, 2018 01:30 PM PST
    Washington's New Opioid Prescribing Rules
    Speaker: Blake Maresh, MPA, CMBE
Posters

POSTER SUBMISSION GUIDELINES

Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.

SUBMIT YOUR ABSTRACT

Enter the following information to this Submission Form:

  • Poster Title
  • Your Name
  • Your Institution
  • Your Email
  • Abstract describing the poster

All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

Questions? Email Posters@LabRoots.com

LabRoots Policy

Speakers

CALL FOR POSTERS

We are always looking to feature excellent research during our virtual events. If you’re working on some remarkable breakthroughs and would like to submit a speaker or panel for consideration, please submit your abstract here.


  • Michael Laposata, MD, PhD
    Professor and Chairman, Department of Pathology, University of Texas Medical Branch-Galveston
    Biography
      Dr. Michael Laposata is the Professor and Chair of the Department of Pathology at the University of Texas Medical Branch-Galveston. He received his M.D. and Ph.D. from Johns Hopkins University School of Medicine and completed a postdoctoral research fellowship and residency in Laboratory Medicine (Clinical Pathology) at Washington University School of Medicine in St. Louis. He took his first faculty position at the University of Pennsylvania School of Medicine in Philadelphia in 1985, where he was an Assistant Professor and Director of the hospital's coagulation laboratory. In 1989, he became Director of Clinical Laboratories at the Massachusetts General Hospital and was appointed to faculty in the Department of Pathology at Harvard Medical School, where he became a tenured full Professor of Pathology. Dr. Laposata joined Vanderbilt University School of Medicine in 2008 where he was the Edward and Nancy Fody Professor of Pathology, Professor of Medicine, and the Pathologist-in-Chief. Dr. Laposata is the recipient of 14 major teaching prizes at Harvard, the Massachusetts General Hospital, and the University of Pennsylvania School of Medicine. His recognitions include the 1989 Lindback Award, a teaching prize with competition across the entire University of Pennsylvania system; the 1998 A. Clifford Barger mentorship award from Harvard Medical School; election to the Harvard Academy of Scholars in 2002, and to the Vanderbilt University School of Medicine Academy for Excellence in Teaching in 2009; and the highest award - by vote of the graduating class - for teaching in years 1 and 2 at Harvard Medical School in 1999, 2000, and 2005. In a peer nominated survey performed by The Pathologist, an international journal reporting on the practice of pathology, the November 2015 issue identified Dr. Laposata as the most influential pathologist in the United States, and the third most influential pathologist in the world.
    • Brenda Suh-Lailam, PhD
      Director, Clinical Chemistry and Point of Care Testing, Ann & Robert H. Lurie Children's Hospital of Chicago
      Biography
        Brenda Suh-Lailam is the Director of Clinical Chemistry and Point-of-Care testing at the Ann & Robert H. Lurie Children's Hospital of Chicago. She is also an Assistant Professor of Pathology at the Northwestern University Feinberg School of Medicine, Chicago, IL. She completed a two-year ComACC-accredited clinical chemistry fellowship at the University Of Utah School Of Medicine / ARUP Laboratories in 2014. Prior to the fellowship, she worked as a research scientist at the ARUP Institute for Clinical and Experimental Pathology after completing doctoral work at Utah State University. Her interests in clinical chemistry are diverse with emphasis in pediatrics and point-of-care testing. She loves spending time with her husband and kids, and does cake decorating whenever she gets a chance.
      • Maude Champagne
        Clinical Oncology Marketing, Illumina, Inc.
        Biography
          Maude is a specialist in molecular biology applications in oncology, across technologies and platforms. Her experience includes contributing to the FDA-approval of 5 Companion Diagnostic (CDx) molecular assays, creating the global go-to-market strategy for a dozen of CDx at various stages in regulatory approval. Maude has educated pathologists and oncologists in early adoption of technologies that have changed medicine and cancer treatments in the last decade.
        • Julie Cichelli, PhD
          LCMS Clinical Application Engineer, Agilent Technologies
          Biography
            Dr. Julie Cichelli obtained her Bachelor's Degree from Villanova University in 2003 with a major in chemistry and a minor in mathematics. She went on to pursue graduate school at the University of Utah, studying under Dr. Zharov, completing her Ph.D. in Organic Chemistry in 2008. Following graduate school in 2009 she accepted a postdoctoral fellowship at the Huntsman Cancer Institute in Salt Lake City researching colon cancer under Dr. Stafforini and Dr. Topham. Subsequently, she joined the Agilent LC/MS applications team in 2010, with a focus in clinical and forensic applications.
          • Phillip Febbo, MD
            Chief Medical Officer, Illumina, Inc.
            Biography
              For the past 25 years, Dr. Febbo has worked at leading institutions throughout the United States, most recently serving as CMO of Genomic Health (NASDAQ:GHDX). Prior to joining Genomic Health, Dr. Febbo served as Professor of Medicine and Urology at the University of California, San Francisco (UCSF), where his laboratory focused on using genomics to understand the biology and clinical behavior of prostate cancer, and his clinical practice focused on genitourinary oncology. While at UCSF, Dr. Febbo was the co-leader of the Prostate Cancer Program at the Helen Diller Family Comprehensive Cancer Center and the Program Principal Investigator of the Translational Research Program for the Alliance for Clinical Trials in Oncology. Dr. Febbo holds a Bachelor of Arts degree in Biology from Dartmouth College, received his M.D. degree at UCSF, and completed his internal medicine residency at the Brigham and Women's Hospital. After his fellowship in medical oncology at the Dana-Farber Cancer Institute, he was an Attending Physician in the Genitourinary Oncology Center at Dana-Farber, Instructor at Harvard Medical School, and a post-doctoral fellow in Dr. Todd Golub's laboratory at Dana-Farber, as well as the Whitehead Institute Center for Genomic Research of MIT (now the Broad Institute). In 2004, Dr. Febbo moved to Duke University Medical Center's Institute of Genome Sciences and Policy. He has been a member of the American Society for Clinical Investigation since 2009.
            • Gary Garrety
              Prescription Monitoring Operations Manager, Health Systems Quality Assurance Division, Washington State Department of Health
              Biography
                Gary Garrety is the Operations Manager for the Prescription Monitoring Program at the Washington State Department of Health. In his ten years of government service for the state of Washington he's worked to support health professionals struggling with substance misuse issues often into recovery. Mr. Garrety's studies focused on Engineering and Mathematics while at Louisiana State University; and on Organizational Development at The Evergreen State College (2007). Gary has overseen operations for the Washington State Department of Health's Prescription Monitoring Program since 2014. He currently serves executive roles for two national committees focused on interstate standards based PMP data exchange.
              • Elaine Gee, PhD
                Founder and President, BigHead Analytics Group
                Biography
                  Elaine Gee, PhD, is the founder and principal consultant of BigHead Analytics Group with industry expertise in clinical bioinformatics and scaling compute platforms for clinical genomic testing. Previously Dr. Gee was the Director of Bioinformatics at ARUP Laboratories, where she supported the bioinformatics and compute infrastructure for clinical next-generation sequencing-based assays. At ARUP she led her team to scale bioinformatics by creating an elastic cloud-based compute infrastructure in AWS that executed standardized bioinformatics pipelines (a.k.a. "Pipey", see https://www.genomeweb.com/clinical-lab-management/arup-launches-cloud-based-ngs-analytics-platform-massively-larger-scale#). This work included tuning somatic and germline pipelines by variant class, developing a central genomic variant datastore to house discrete genomic data, and automating and scaling the infrastructure. Additionally her work included incorporation of unique molecular identifiers to enable low frequency variant detection and creation of tools to optimize NGS target design in low complexity genomic regions. Dr. Gee pairs analytic rigor with automation and design architecture to scale bioinformatics solutions and accelerate the pipeline development life cycle. Her background includes cross-disciplinary experience in machine learning, signal processing, molecular dynamics modeling, and instrument integration and control. Dr. Gee earned her Ph.D. in biophysics from Harvard University and a B.S. in physics from the California Institute of Technology. She currently serves as the informatics subdivision lead on the AMP Global 2019 Organizing Committee and works at Medtronic as a Principal Machine Learning Algorithm Development Engineer.
                • Blake Maresh, MPA, CMBE
                  Deputy Director, Office of Health Professions, Washington Department of Health
                  Biography
                    Blake has served as Executive Director with the Washington State Department of Health since November 2004. During his tenure, he has had responsibility for nine different health professions boards and commissions, as well as many Secretary-regulated professions. In addition to these responsibilities, over the past year, Blake has served as co-lead in the enactment of opioid prescribing rules for five boards and commissions, as required by 2017 HB 1427. Between 2006 and 2014, Blake served on the Board of Directors of Administrators in Medicine (AIM), an organization of medical and osteopathic board executives from across the US, including serving as President of the organization from 2009 to 2012. A Certified Medical Board Executive since April 2009, Blake was honored in 2014 with AIM's Doug Cerf Executive Director's Award. Blake also served on the Board of Directors of the Federation of State Medical Boards (FSMB) from 2012-2014. Since 2012, he has been a leader in the development of an interstate compact for physician licensure and was a member of the team that drafted the Interstate Medical Licensure Compact. He currently serves as Commissioner for the Washington Osteopathic Board, and he holds the office of Treasurer of the Interstate Medical Licensure Compact Commission. Blake received his BA at the University of Puget Sound and his Masters in Public Administration from the University of Washington-Evans School of Public Policy and Governance.
                  • Olivera Markovic, MD, PhD
                    President, Global Academy for Women's Health and Director at BioSciCon, Inc.
                    Biography
                      Dr. Olivera Markovic is a medical doctor, Ph.D in biomedical sciences, academician, cancer research scientist, entrepreneur and author. She is President of Global Academy for Women's Health and Director of BioSciCon, Inc. Dr. Markovic is experienced academician being elected professor/visiting/adjunct professor at six universities/medical schools: Universities in Belgrade and Skopje (Former Yugoslavia), Medical College of Pennsylvania (now Drexel University, Philadelphia, PA), Georgetown University, American University (Washington, DC), and University of Maryland Baltimore County (Baltimore, MD). Teaching was her vocation for 30 years, and she taught students from undergraduate, graduate, doctoral and postdoctoral level, including adult education. She taught basic medical sciences at medical schools, and science courses in colleges and universities in Washington Metro Area (Biochemistry, Biochemistry and Health, General Biology, Anatomy and Physiology, Pathophysiology, Human Body in Health and Disease, Clinical Chemistry, Biotechnology). She has long experience of reviewing the work of others, including student's projects, master and doctoral theses, scientific papers and books. Invited speaker for many national and international meetings. During the last two decades, her research interest has been devoted to the improvement of the methodology for early cervical cancer detection and making it available to women around the world. She and Dr. Nenad Markovic developed a new biomarker-based, IT/mobile empowered, infrastructure independent MarkPap(r) platform technology. Supported by NIH, they conducted translational research from an idea to commercial MarkPap® line of products and proposed a new strategy for fighting this disease globally. Cervical cancer is completely preventable and curable disease IF detected on time by screening. Dr. Markovic authored more than 200 scientific publications including books, chapters in books, invited review articles, scientific papers and patents. Author of the book "What every woman should know about cervical cancer", Springer 2008, 2010. The Second updated and extended edition was published in 2017 http://www.springer.com/biomed/cancer/book/978-1-4020-6936-9 www.amazon.com Global Academy for Women's Health is a non-profit organization with a mission to advance science and education in women's health globally (www.markpap.com). In August 2018, together with BioSciCon, awarded with the healthcare and pharmaceutical award Best for Women's Health Promotion Maryland by Global Health and Pharma.
                    • John McDonough
                      President and CEO, T2 Biosystems
                      Biography
                        At the helm of T2 Biosystems, Mr. McDonough and his team took a new technology concept from MIT and MGH and grew it into a publicly-traded company that has the first and only FDA-cleared diagnostic products to directly detect sepsis-causing pathogens in blood. T2Direct Diagnostics™ are improving patient care in over 160 hospitals worldwide - helping patients with potentially life-threatening illness receive targeted treatment as much as eight times faster.
                      • Chris Meijer, MD, PhD
                        CEO Self-Screen, Emeritus Professor of Pathology, VUmc
                        Biography
                          hris Meijer MD, PhD, has been a surgical pathologist since 1977. He performs translational research in the field of oncology with emphasis on HPV and HPV-associated cancers. He was chairman of the Department of Pathology, VU-UMC Amsterdam from 1983-2010 and has been awarded for his research on numerous occasions by (Inter)national organizations. Presently, he leads a research group focusing on the development of a full molecular cervical cancer self-screening algorithm and is a part-time director of Self-Screen bv, a company that develops diagnostic molecular tests for cervical (pre)cancer.
                        • Jennifer Poitras, PhD
                          Principal Genome Scientist, QIAGEN
                          Biography
                            Jennifer received a B.S. in Genetics from the University of Connecticut and went on to receive a Ph.D. in Human Genetics at the Johns Hopkins School of Medicine. During her graduate training, she used Ingenuity Pathway Analysis and was so impressed with the tool that she approached QIAGEN for the opportunity to support their bioinformatics portfolio. Currently, she is the lead genome scientist supporting QIAGEN's software solutions for analysis and interpretation of variants implicated in hereditary disease.
                          • Dan Richards, PhD
                            Vice President, Biomedical Informatics, QIAGEN
                            Biography
                              Dan Richards is Vice President, Biomedical Informatics at QIAGEN, where he focuses on the automated interpretation of molecular variation in the context of current clinical evidence. Dan earned his Ph.D. in Human Genetics from Stanford University and co-founded Ingenuity Systems, whose analysis applications and manually-curated knowledge base of peer-reviewed scientific literature are used by scientists and clinicians worldwide to interpret genomic data in the context of current biomedical knowledge.
                            • Raed Samara, PhD
                              Senior Global Product Manager, NGS, QIAGEN
                              Biography
                                Raed Samara, PhD is a Global Product Manager for NGS technologies at QIAGEN, with a focus on pre-analytics and targeted enrichment. Prior to joining QIAGEN, he was a postdoctoral fellow at the National Cancer Institute conducting research in the field of cancer immunology with emphasis on identifying strategies to boost the efficacy of cancer vaccines. He received his Ph.D. degree from Georgetown University in tumor biology.
                              • Ravinder Singh, PhD
                                Director, Endocrine Laboratory, Mayo Clinic
                                Biography
                                  Ravinder J. Singh, Ph.D., is the director of the Mayo Clinic Endocrine Laboratory. He has a focused area of investigation that has broad applicability to the field. Dr. Singh studies the application of liquid chromatography-tandem mass spectrometry (LC-MS/MS) to clinical laboratory analysis. Many of the methods that Dr. Singh developed are now considered reference methods. They have subsequently been utilized for method standardization efforts as well as to establish clinical disease correlates, which he has published with his collaborators. Dr. Singh's work has directly contributed to improving methods for the clinical diagnosis of Cushing's disease, pheochromocytoma and congenital adrenal hyperplasia. He continues to work to discover innovative ways to better understand the uses of LC-MS/MS in providing patients with faster and more accurate diagnoses.
                                • Carissa van den Berk-Clark, PhD
                                  Assistant Professor, Research Division, Department of Family and Community Medicine, Saint Louis University School of Medicine
                                  Biography
                                    Dr. van den Berk-Clark has over 15 years of community and human service experience in urban centers including St. Louis, Philadelphia, New York, Minneapolis and Los Angeles. Her work in these communities focused on improving the quality of life, well-being and health outcomes of low-income African American residents. While receiving her doctorate at UCLA, she conducted a 4-year ethnographic study of homeless living on skid row. She also was employed as a health science administrator at the West Los Angeles Veterans Administration (VA) where she worked with the National Director of Justice Programs on a range of different implementation studies of VA programs for homeless and incarcerated veterans. She later moved back to St. Louis to embark on additional post-doctoral training in psychiatric epidemiology at Washington University's School of Medicine (Department of Psychiatry). There she received extensive training in psychiatric epidemiology, behavioral economics and addictions research. Since arriving at Saint Louis University, Carissa's research has focused on access to and utilization of health services by vulnerable groups. She uses approaches focused on system level barriers as well as individual barriers such as factors affecting "rational choice" like poverty, stigma, trauma exposure and substance use. In addition, Dr. van den Berk-Clark serves as a Research Scientist at the Community Academic Partnership for Addictions, Washington University Brown School of Social Work. Dr. van den Berk-Clark enjoys sewing, the local arts community and fiction writing as well as spending time with her husband Ben, their daughter Ramona and dog Gorilla.
                                  • Bing Zhou, PhD
                                    Sr. Scientist, Bioinformatics, QIAGEN
                                    Biography
                                      Dr. Zhou is a professional scientist with more than 10 years of experience in oncology, cancer genetics, and preclinical drug discovery. She previously works as research associate in the Lineberger Cancer Center of University of Carolina at Chapel Hill, where her interests are centered around molecular mechanisms of breast cancer and prostate cancer using animal models. Her experiences in industry includes target discovery and validation, cell-based assay development, and small molecules screening. Currently, Bing is managing Oncoland curation team within OmicSoft, a QIAGEN company. So far, OncoLand curation team has curated thousands of projects from cancer genomics consortia as well as public data repositories. Her knowledge on cancer biology and clinical ontologies has supported the establishment of internal curation standards.
                                    Sponsored By

                                    For information on becoming a sponsor or exhibitor, please click here.


                                    C.E. Credits

                                    The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here

                                    The presentational method for this activity will be Lecture with an opportunity for real-time question and answer periods for the live activity, and on demand access of the presentation for the enduring material activity. Both the internet live course and the internet activity enduring material are geared towards Laboratory Clinicians, Primary Care Clinicians, and those involved in clinical testing and diagnostics. This activity will encompass the following desirable physician attributes:  Patient Care & Procedural Skills, Medical Knowledge, Professionalism, Interpersonal & Communication Skills, Practice-Based Learning & Improvement, and Systems-Based Practice.

                                    Desired Outcomes

                                    At the end of the activity, participants should be able to:

                                    1. Contrast previous and newly released guidelines
                                    2. Take action to increase partnership and collaboration with clinicians
                                    3. Identify actions that can be taken to deliver quality results faster to clinicians
                                    4. Better define personalized healthcare today and explain the role of companion diagnostics
                                    5. Utilize diagnostic tools optimally in patient work-ups
                                    6. Identify the role of the clinical laboratory in contributing to or preventing diagnostic errors

                                    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CME Consultants and LabRoots. CME Consultants is accredited by the ACCME to provide continuing medical education for physicians.

                                    CME Consultants designates this internet live activity for a maximum of 4.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

                                    CME Consultants designates this internet activity enduring material for a maximum of 4.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

                                    Enduring Material release date: 11/16/18

                                    Enduring Material Termination date: 2/16/18

                                    In accordance with the Americans with Disability Act (ADA), please contact LabRoots at ce@labroots.com should you require special assistance.


                                    Committee

                                    To download the Program Committee brochure here.


                                    • Sihe Wang, PhD DABCC FACB

                                      Dr. Sihe Wang is Section Head and Medical Director of Clinical Biochemistry and Director of Clinical Biochemistry Fellowship Training Program, Cleveland Clinic, Cleveland, Ohio. He also chairs the clinical chemistry integration effort for the Cleveland Clinic Health System which ...

                                      See more See less
                                    • Cynthia Bowman, MD

                                      Dr. Cynthia Bowman has been a broad based general pathologist for over 30 years. She graduated with a BA in Chemistry from St. Olaf College, received her MD from Vanderbilt University Medical School, and trained for 6 years at the University of California, San Francisco as a ...

                                      See more See less
                                    • George Fritsma, MS, MT

                                      George Fritsma is an associate professor in Laboratory Medicine of the Department of Pathology at the University of Alabama at Birmingham. Prof. Fritsma manages www.fritsmafactor.com, "The Fritsma Factor, Your Interactive Hemostasis Resource," a clinical coagulation ...

                                      See more See less
                                    • Damien Gruson, PhD, EuSpLM, FESC

                                      Professor Damien Gruson was awarded his degree of Pharmacist in 2000 and of Specialist in Laboratory Medicine in 2005 from the Catholic University of Louvain, Brussels, Belgium. Pr. D. Gruson fulfilled is PhD thesis entitled "Regulation and Physiopathology of Urotensin II and ...

                                      See more See less
                                    • Michael Holick, MD, PhD

                                      Michael F. Holick, Ph.D., M.D. is Professor of Medicine, Physiology and Biophysics; Director of the General Clinical Research Unit; and Director of the Bone Health Care Clinic and the Director of the Vitamin D, Skin and Bone Research Laboratory at Boston University Medical ...

                                      See more See less
                                    • Bruce Hollis, PhD

                                      Bruce W. Hollis, Ph.D. received his B.Sc. and M.Sc. from the Ohio State University and subsequently his Ph.D. from the University of Guelph in 1979. Dr. Hollis then completed an Endocrine Fellowship at The Case Western Reserve University School of Medicine in 1982. Dr. Hollis ...

                                      See more See less
                                    • Kamisha Johnson-Davis, PhD, DABCC, FACB

                                      Dr. Johnson-Davis is a medical director of the Clinical Toxicology laboratory, Antifungal Testing and Immunosuppressants Testing at ARUP. Dr. Johnson-Davis received her PhD in pharmacology at the University of Utah and is board certified in clinical chemistry by the American ...

                                      See more See less
                                    • Alan Maisel, MD

                                      Dr. Alan Maisel attended University of Michigan Medical School and did his cardiology training at the University of California at San Diego. He is currently Professor of Medicine at the University and director of the coronary care unit and the heart failure program at the ...

                                      See more See less
                                    • Brian McNally, PhD

                                      Brian McNally received his doctorate in Cell & Molecular Biology at University of Texas Southwestern Medical Center, where he focused on the transcriptional mechanisms governing polycystic kidney disease, renal cancer and development. His post-doctoral fellowship concentrated on ...

                                      See more See less
                                    • Alan Wright, MD

                                      Dr. Wright is the Chief Medical Officer at Roche Diagnostics Corporation in Indianapolis, Indiana. Prior to joining Roche, Dr. Wright served as Senior Vice President of Health Improvement Strategies for Miraca Life Sciences. He was the Vice President for Product Strategy and ...

                                      See more See less
                                    Help

                                    General LabRoots Questions

                                    For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                                    Contact us

                                    Virtual Events and Webinars

                                    Supported Configurations

                                    • Operating System Internet Explorer Firefox Chrome Safari
                                      Vista IE8+ FF10+ Chrome15+
                                      Windows 7 IE8+ FF10+ Chrome15+
                                      Windows 8 IE10 FF10+ Chrome15+
                                      Mac OS X   FF10+ Chrome15+ Safari5.1+
                                    • Cookie settings: session cookies enabled
                                    • Browser configuration must have JavaScript enabled
                                    • Adobe Flash player 10.2 or later

                                    To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                    Internet Connection

                                    • A minimum of 100Kbps is recommended for audio-only events
                                    • A minimum of 300Kbps is recommended for speaker on-video events

                                    Computer Equipment

                                    • Screen Resolution: Minimum 1024x768
                                    • Video Card: 65,000 colors minimum
                                    • Sound card and speakers (or headphones) for hearing webcast in full format
                                    • Audio Card: 16-bit minimum
                                    • RAM: 512MB of free RAM

                                    Firewall Protocol

                                    • HTTP on port 80 or HTTPS on port 443
                                    • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                    • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                    Work-At-Home Attendees

                                    • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                    For A Seamless Experience

                                    When using a mobile device, FREE Mobile Apps are available:

                                    - For viewing Webinars:

                                    - For viewing Virtual Events

                                    Attendee Guide

                                    • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                    Virtual Event and Webinar Support:

                                    Continuing Education (CME/CE) Support

                                    Loading Comments...
                                    Show Resources